🚨 New insights from Annals of Internal Medicine challenge long-held beliefs about alcohol 🍷 and health 🧬.

A 2025 U.S. Surgeon General advisory links even modest drinking to increased cancer risk 🎗️—especially breast and oral cancers. Experts now urge clearer labeling, better patient counseling 🩺, and culturally normalizing abstinence 🌱.

Is it time to rethink the “glass of red wine” advice?

🧐 #PublicHealth #AlcoholAwareness #PreventiveMedicine #AnnalsOfIM

💡 Renal Denervation: A New Era in Hypertension Care 🩺

Despite decades of effective medications, only ~25% of patients worldwide achieve blood pressure control. Non-adherence remains a huge barrier. 📉

This Nature Reviews Cardiology article (Fisher & Kirtane, Sept 2025) explores the journey of renal denervation (RDN) — from Smithwick’s sympathectomy in the 1950s to today’s FDA-approved radiofrequency 🔥 and ultrasound 🔊 catheter systems.

✅ Sham-controlled trials show RDN lowers BP by 5–10 mmHg, similar to one effective antihypertensive drug.

✅ Durable safety profile, up to 10 years in registries.

✅ Best suited for resistant hypertension, drug intolerance, or pill fatigue.

✅ Implementation requires multidisciplinary teams and shared decision-making. 🤝

🚀 Future: Expanding to underrepresented populations, CKD, elderly, and even beyond hypertension (AFib, sleep apnea, metabolic syndrome).

👉 A fascinating example of how history, technology, and evidence converge to reshape cardiovascular medicine.

📘 New Insights on Diverticulitis 📊🔬💊

Did you know that while 1–4% of people with diverticulosis develop diverticulitis, it still accounts for ~200,000 hospitalizations annually in the US and >$6.3B in healthcare costs? 🚑💰

✅ CT scan remains the gold standard for diagnosis 🖼️

✅ Observation & pain control are first-line for uncomplicated cases 💊

✅ Antibiotics reserved for high-risk groups (elderly, immunocompromised, pregnant, systemic illness) ⚠️

✅ Surgery indicated for recurrent or complicated cases (fistula, stricture, perforation) ✂️

This JAMA 2025 review emphasizes precision in management—avoiding overtreatment while protecting vulnerable patients 👥.

👉 How do you approach antibiotic stewardship in diverticulitis care?

🚨 Hypertension remains the world’s #1 killer — yet fewer than 1 in 4 patients achieve control.

💊 Exciting innovations are reshaping the field:

✔️ Aprocitentan (endothelin receptor antagonist) – first new class in decades

✔️ siRNA (zilebesiran) – 6-monthly dosing, tackling adherence

✔️ Aldosterone synthase inhibitors – overcoming “aldosterone escape”

✔️ Non-steroidal MRAs & neprilysin inhibitors – precision targeting with broader benefits

✔️ Single-pill & quadpill combos – simplifying therapy, boosting adherence

🌍 Together, these therapies + smarter management could transform outcomes in resistant and uncontrolled hypertension.

🌟 Ramanuja (1017–1137 CE), one of India’s greatest theologians, shaped Vishishtadvaita Vedanta (Qualified Non-Dualism). His vision of Atman (self) and Brahman (supreme reality), united through bhakti (devotion), transformed Hindu theology and inspired generations. 🕉️📖

💡 His commentaries on the Upanishads, Bhagavad Gita, and Brahma Sutras laid the foundation of Sri Vaishnavism and emphasized a path of devotion, grace, and liberation (moksha). ✨

🙏 A reminder for today’s healthcare providers and leaders: true service blends knowledge, humility, and compassion. ❤️🩺

#Philosophy #Ramanuja #Vedanta #Leadership #Wisdom #Compassion

🧬 South Asians make up 25% of the world—yet just 3% of major cardiovascular trials.

A new systematic review (310 RCTs, 1M+ participants) reveals stark underrepresentation, especially outside India.

No South Asians in trials for heart failure, cardiac arrest, or valvular disease.

📉 The data gap is real—and it’s limiting care.

🔍 We need global trial designs that are inclusive, disaggregated, and powered for equity.

Let’s change the research playbook. 💡

#CardioTrials #SouthAsianHealth #DiversityInResearch #PrecisionMedicine #GlobalHealth 🌏🫀📊

🚶‍♀️📲 New research alert! A massive natural experiment tracking 7,447 relocations across 1,609 US cities reveals that urban walkability directly boosts physical activity 🏙️💪

📈 Moving to more walkable cities increased daily steps by ~1,100 and doubled compliance with MVPA guidelines!

🎯 A powerful case for urban design as preventive medicine.

🔗 A must-read for public health advocates, city planners, and digital health innovators!

#Walkability #UrbanHealth #DigitalEpidemiology #MVPA #SmartCities #BuiltEnvironment #PublicHealth 🏃‍♂️🌆

🧂 Salt sensitivity of blood pressure (SSBP) is an independent risk factor for CVD.

🚹🚺 Women are more salt-sensitive than men, especially after menopause.

⚙️ Key drivers: RAAS, ENaC, natriuresis, and immune pathways.

💉 Estrogen protects, testosterone raises pressure, menopause tips the balance.

🐀 From Dahl’s rats to Conn’s syndrome, SSBP research shows why sex-specific, personalized therapy is the future of hypertension care.

🔗 Nature Reviews Cardiology

Liver, Lipids, and the Left Ventricle 🩸🫀🧬

The NEJM review reminds us that fatty liver isn’t just a liver problem. MASLD drives risk for heart disease, diabetes, kidney dysfunction, and even cancers. 🚨

Cardiovascular disease remains the leading cause of death in MASLD—outpacing cirrhosis and cancer. 🫀💔

With new tools like FIB-4, VCTE, ELF, and promising drugs such as resmetirom and GLP-1/GIP agonists, we’re entering an era where treating the liver can protect the heart. 💊🌱

#MASLD #LiverHeartConnection #NEJM #CardiometabolicHealth

🧓💊 The COMBINE-AF substudy offers important guidance for managing frail, elderly, VKA-experienced patients with atrial fibrillation.

Switching to standard-dose DOACs reduced stroke/systemic embolism risk and cut intracranial & fatal bleeding 🧠🛡️, but raised gastrointestinal bleeding rates 🍽️🩸—especially with certain agents.

Sensitivity analyses show apixaban & edoxaban may offer a safer bleeding profile.

These findings highlight the need for shared decision-making ⚖️ and integrated ABC pathway care ❤️ to balance prevention, safety, and patient preferences. #AFib #Cardiology #PrecisionMedicine